Stocks to sell

Not all businesses in the U.S. were hurt by the Covid-19 pandemic lockdowns. In fact, many companies produced some of their best financial results ever in 2020. Retailers that had a strong omni-channel presence did quite well, including Target (NYSE:TGT). And TGT stock benefitted as well. Source: Robert Gregory Griffeth / Shutterstock.com This 100-year-old retailer
0 Comments
Aphria (NASDAQ:APHA) stock could be in trouble. The company reported terrible fiscal third-quarter results on April 12, indicating that my negative thesis on marijuana stocks remains very much intact. Source: Shutterstock Moreover, the outlook of Aphria’s merger partner, Tilray (NASDAQ:TLRY), is worsening. Given these points, I recommend that investors sell APHA stock. There are new indications
0 Comments
With shares holding steady for the past month, should you buy the pullback in electric-vehicle (EV) maker Nio (NYSE:NIO)? Not so fast. NIO stock still remains popular among investors, even after its more than 40% slide from its all-time highs. Source: xiaorui / Shutterstock.com As I detailed back on Apr. 9, investors were satisfied with
0 Comments
Canoo (NASDAQ:GOEV) closed its SPAC (special purpose acquisition company) merger on Dec. 21, 2020, and received $607 million. Since then, however, GOEV stock has dropped precipitously. Source: Shutterstock In fact, Canoo has not announced the production partners for its Canoo lifestyle electric vehicle (EV). Maybe this has something to do with the fall in GOEV
0 Comments
Rationality is coming back to the pricing of Zomedica (NYSEAMERICAN:ZOM) stock. Source: Postmodern Studio / Shutterstock.com Investors may have been highly bullish on the prospects of Truforma, the company’s veterinary diagnostics platform. But trading leaps and bounds above the potential long-term upside from this catalyst, it was inevitable shares were going to pull back in
0 Comments